Maynard Um
-
-
-
-
-
-
-
Jones Trading stays Buy on Precision BioSciences Inc. (DTIL) following Ph1/2 trial design announcement
-
-
-
-
-
-
-
Precision BioSciences (DTIL) files $250M mixed shelf
-
-
-
-
-
-
-
Precision BioSciences receives U.S. patent for hepatitis B gene therapy
-
-
-
-
-
-
-
Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Announces Initial Safety and Antiviral Activity of PBGENE-HBV
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Presents Preclinical Data Highlighting the Capability of ARCUS
-
-
-
-
-
403,363 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

